Performance Marketing and an Undisclosed Personal Holding
Priya is a CAIA charterholder and investment analyst at a fund-of-funds. She is completing a due-diligence questionnaire for a $150 million allocation to a hedge fund. The fund's investor letter reports a 2024 gross return of +18.4%, while audited financials show +11.2% net. Mid-year, the fund changed valuation of a Level 3 private position from an independent model to a management estimate, raising NAV by 6%. The GP asks Priya to use the +18.4% figure and omit the valuation change, saying competitors do the same. Priya's supervisor agrees and suggests a vague footnote. Priya also personally owns $12,000 of the GP's listed affiliate stock, which she has not disclosed internally. The DDQ is due tomorrow.
1. Identify the professional-standards issues in Priya's situation and explain what she must do before the DDQ is submitted.
Read the worked answer
The central issues are misrepresentation, performance presentation, conflicts of interest, and diligence. Using +18.4% gross without clearly labeling it as gross and reconciling it to the audited +11.2% net would mislead allocators. Omitting a material mid-year valuation-policy change that raised NAV by 6% is also a material omission; a vague footnote does not cure it because the reader cannot assess the effect. Priya's undisclosed personal holding in the GP's affiliate creates an actual conflict and must be disclosed internally, with recusal from the allocation decision if required by policy. Before submission she should: (1) present gross and net returns side by side, with the fee and expense basis; (2) disclose the valuation-policy change and its NAV effect; (3) disclose the personal holding to compliance and recuse herself from recommendation/voting; and (4) document the GP's request and her supervisor's instruction. She should not sign or submit a document she knows is misleading.
2. Priya's supervisor insists that the DDQ go out as written because 'the GP will walk otherwise.' How should she respond, and what escalation is appropriate?
Read the worked answer
Priya should refuse to submit the misleading DDQ and explain the specific consequences: misrepresentation to prospective investors, inconsistent performance presentation, and an undisclosed conflict. She should propose a compliant alternative: include the audited net return, disclose the valuation change and its 6% NAV impact, and add a clear conflict-of-interest disclosure with her recusal. If the supervisor still insists, she should escalate to compliance or the firm's ethics/legal function, in writing, and preserve the draft, emails, and relevant performance records. Confidentiality does not prevent internal escalation; it prevents public disclosure of the GP's confidential information. She should not threaten external disclosure unless required by law or firm policy. The correct professional judgment is that losing the allocation is preferable to facilitating a misleading marketing document.